Malaria: Vaccination

(asked on 11th May 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of the malaria vaccine produced by research at Oxford University on the spread of the disease worldwide.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 17th May 2021

Results from the Phase IIb trial of the R21/MATRIX-m malaria vaccine produced by research at Oxford University, conducted in Burkina Faso, showed vaccine efficacy of 77% in a 12-month follow up period. The vaccine is the first to meet the World Health Organization’s malaria vaccine group goal of at least 75% vaccine efficacy.

Recruitment for a large Phase III (Safety and Efficacy) trial in more than 4,000 children has now begun. The potential benefit from adding a highly effective malaria vaccine to these measures is substantial and Public Health England will continue to monitor its effect on malaria transmission.

Reticulating Splines